Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 26186

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2024 | Month : November | Volume : 18 | Issue : 11 | Page : DC01 - DC05 Full Version

A Cross Sectional Study on Detection of Human Adenovirus from Clinical Samples of Conjunctivitis by Real Time PCR and Viral Cell Culture


Published: November 1, 2024 | DOI: https://doi.org/10.7860/JCDR/2024/72529.20232
Ashish Anshuman, MJ Praseetha, Ambica Rangaiah, G Nagaraju, M Swetha, Shantala Gowdara Basawarajappa

1. Assistant Professor, Department of Microbiology, Dr Chandramma Dayananda Sagar Institute of Medical Education and Research (CDSIMER), Bengaluru, Karnataka, India. 2. Fellow, Department of State Level VRDL and Microbiology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India. 3. Professor, Department of Microbiology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India. 4. Director, Professor and Head, Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India. 5. Assistant Professor, Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India. 6. Professor, Department of State Level VRDL and Microbiology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.

Correspondence Address :
Dr. Shantala Gowdara Basawarajappa,
Professor and Principal Investigator, Department of Microbiology, State Level VRDL, Bangalore Medical College and Research Institute, Bengaluru-560002, Karnataka, India.
E-mail: drshantalagb@gmail.com

Abstract

Introduction: Human Adenoviruses (HAdV) have been implicated in a variety of infections, including conjunctivitis, respiratory tract infections, genitourinary infections and gastroenteritis. Epidemic Keratoconjunctivitis (EKC) is a severe ocular surface infection strongly associated with HAdV, known to occur in widespread outbreaks. HAdV species B, D and E are associated with ocular manifestations ranging from simple follicular conjunctivitis (types 3, 4, 7) and pharyngoconjunctival fever (types 3, 7, 14) to the more severe EKC (types 8, 19, 37, 53, 54, 56 and 64). Viral cell cultures of conjunctival specimens help confirm adenovirus infection through the characteristic Cytopathic Effect (CPE) and Polymerase Chain Reaction (PCR) is the best standard method to diagnose viral conjunctivitis due to its sensitivity, accuracy and rapidity.

Aim: To diagnose HAdV in clinically suspected cases of viral conjunctivitis using real-time PCR. To isolate HAdV in viral cell culture and confirm it by observing its characteristic CPE and performing adenoviral real-time PCR.

Materials and Methods: A cross-sectional descriptive study was conducted from July 2023 to September 2023 at the state-level Virus Research and Diagnostic Laboratory (VRDL) at Bangalore Medical College and Research Institute (BMCRI), Bengaluru, Karnataka, India. A total of 45 conjunctival swab samples from patients with suspected viral conjunctivitis, who attended the Ophthalmology Outpatient Department (OPD) or were admitted to the wards, were included in the study. Conjunctival swab samples collected in Viral Transport Medium (VTM) were centrifuged at 3000 rpm for five minutes at 4°C. Real-time PCR was performed and samples positive for HAdV by real-time PCR were taken up for viral cell culture. Confirmatory PCR was conducted for samples showing CPEs in the cell line. The data collected were analysed using descriptive statistics.

Results: The majority of patients in the present study were in the age group of 18-45 years, comprising 25 (56%) of the total patients. Out of 45 conjunctival samples tested, 8 samples were positive in adenovirus real-time PCR. All eight PCR-positive samples showed a CPE in viral cell culture on the A549 cell line. The study found PCR positivity in 8 samples (17.7%), while adenoviral recovery from cell culture was observed in 6 samples (13.3%).

Conclusion: Real-time PCR has become the standard diagnostic procedure for detecting adenovirus conjunctivitis. Rapid and accurate diagnosis is key to interrupting the contagious spread of adenoviral conjunctivitis, along with timely treatment.

Keywords

Adenoviral conjunctivitis, Diagnosis, Epidemic keratoconjunctivitis, Polymerase chain reaction

The HAdVs have been implicated in a variety of infections, including conjunctivitis, respiratory tract infections, genitourinary infections and gastroenteritis (1). HAdV is a known cause of severe ocular surface infections, specifically EKC, which is known to occur in extensive outbreaks. Conjunctival symptoms can vary from hyper-acute, exudative conjunctivitis with the formation of conjunctival membranes to moderate follicular conjunctivitis. Adenoviral conjunctivitis can lead to subepithelial infiltrates, which may persist or recur months to years after the acute infection has resolved. This condition can also cause punctate or geographic epithelial keratitis, which may culminate in stromal keratitis (1).

The HAdVs were initially classified into 51 types based on serum neutralisation and haemagglutination inhibition. The epsilon determinant, an epitope on the hexon protein generated by two hypervariable loops programmed at the genome level by hypervariable regions 16 and 7, respectively, is responsible for serum neutralisation. Haemagglutination inhibition is a property of the fibre protein. Recently, using whole genome sequencing, HAdVs have been classified into 7 species (A-G) and 103 genotypes in GenBank (2). The association between ocular surface infections and HAdV species B, D and E is well-established. The disease can cause a range of symptoms, from pharyngoconjunctival fever (types 3, 7, 14) and simple follicular conjunctivitis (types 3, 4, 7) to more severe EKC (types 8, 19, 37, 53, 54, 56 and 64). Worldwide, genotype 8 is more prevalent, being involved in 44% to 100% of EKC outbreaks, whereas type 4 is implicated in 7% to 11% of outbreaks (3). Studies from South India have reported the presence of types 8 and 4 (4),(5). Previous studies from India have shown a prevalence of 13.8% to 66.6% for HAdV among patients with keratoconjunctivitis (6).

The traditional gold standard for diagnosing EKC or any adenovirus conjunctivitis has been Cell Culture in Combination with Immunofluorescence staining (CC-IFA) and characteristic CPEs (2),(3),(4). Various cell lines are used for adenovirus cultivation, including A549, Hep-2, HeLa and 3T6 cell lines (7). PCR, direct immunofluorescence and rapid antigen-detection immunoassays are also utilised to diagnose viral conjunctivitis. While viral cell cultures of the conjunctival specimen can help in confirming adenovirus through immunofluorescence and characteristic CPEs, they are less frequently used due to the requirement for elaborate equipment, specialised facilities, trained laboratory staff and significantly increased turnaround time (7). PCR is considered the best standard method for diagnosing viral conjunctivitis due to its sensitivity, accuracy and rapid results, along with less technical involvement (7),(8). Most PCR assays target the more conserved penton or hexon region sequences for detecting adenoviruses (5),(6).

As mentioned earlier, EKC or adenoviral conjunctivitis is a severe ocular surface infection characterised by punctate or geographic epithelial keratitis, leading to chronic keratitis with reduced visual acuity, which can be debilitating. HAdVs cause periodic outbreaks due to their highly contagious nature in a wide range of settings, such as military recruits or hospitals. Community-based EKC outbreaks are common and are usually transmitted from person to person via respiratory or ocular secretions, by fingers, or through contaminated ophthalmologic instruments. In fact, most described epidemic outbreaks represent infections from a common source, which may include inadequately chlorinated swimming pools or contaminated ophthalmology units (1),(3),(4).

Laboratory confirmation of the diagnosis can guide physicians in rapidly initiating appropriate hygienic measures and determining the epidemiological significance of the infection (9). Early rapid and accurate diagnosis helps limit the spread of the disease and accelerates recovery in patients through timely and appropriate treatment measures (5),(8),(10).

The current study aimed to detect adenovirus from clinical samples of conjunctivitis through real-time PCR and to isolate HAdV in viral cell culture, confirming it by its characteristic CPE and adenoviral real-time PCR. The present study updates the current state of knowledge regarding the efficacy of viral cell culture and real-time PCR in diagnosing adenoviral conjunctivitis, which is especially crucial as diagnostic methods advance and new technologies become accessible. The study’s findings may have implications for public health strategies, including outbreak management and preventive measures. Rapid and accurate diagnosis can facilitate the timely implementation of isolation protocols.

Material and Methods

The present cross-sectional descriptive study was conducted at the state-level VRDL laboratory at Bangalore Medical College and Research Institute, Bengaluru, from July 2023 to September 2023, after obtaining ethical clearance from the Institutional Ethical Committee (No: BMCRI/EC/11/23-24).

Sample size calculation: The sample size was calculated according to the study by Sharmila F et al., which reported a prevalence of adenoviral conjunctivitis of 47.8% (11).

Sample formula: 4PQ/d2

Prevalence (P)- 47.8% Q= 100-P= 40
Allowable error (d)= 15%
Sample Size= 44.35
Sample Size= 45

A total of 45 conjunctival samples from suspected cases of viral conjunctivitis, who attended the Ophthalmology OPD and were admitted to the wards, were included in the study.

Inclusion criteria:

• Patients willing to provide informed consent.
• Patients aged eight years and older.
• Patients clinically diagnosed with unilateral or bilateral acute onset of conjunctivitis, acute haemorrhagic conjunctivitis, or conjunctivitis with watery discharge.
• Patients with a recent history of unilateral or bilateral acute onset of conjunctivitis, acute haemorrhagic conjunctivitis, or conjunctivitis with watery discharge among family members.

Exclusion criteria: Clinically diagnosed patients with conjunctivitis associated with mucopurulent or purulent discharge, suggestive of bacterial and allergic/chemical aetiology, as well as contact lens wearers were excluded from the study.

Study Procedure

Each specimen in the VTM was vortexed intermittently for 1 minute, then aliquoted into sterile Eppendorf tubes and centrifuged at 3000 rpm for 5 minutes at 4°C. The supernatant was used for viral culture and molecular assays.

Viral cell culture: A 500 μL of supernatant from each sample was inoculated into a tissue culture flask (T25) containing an appropriate, healthy A549 cell line with a confluence of ≥ 70%, which was devoid of any cytoplasmic granulation and rounded cells (12). Fresh A549 flasks were procured from the National Centre for Cell Science (NCCS), Pune and maintained at the State Level Virus Research and Diagnostic Laboratory, BMCRI, Bengaluru. The inoculated cell lines were incubated at 37°C and observed daily for up to seven days for the characteristic CPE of adenovirus, which is characterised by grape-like clusters of cells. The CPE was confirmed by performing real-time PCR on the viral cell medium once growth was evidenced.

The QIAamp Deoxyribonucleic Acid (DNA) Mini Kit (Qiagen, Hilden, Germany) was utilised to extract viral DNA from 200 μL of the supernatant fluid, in accordance with the manufacturer’s instructions. If no CPEs were observed within seven days, a blind passage was performed using a new A549 cell line flask, which was then observed for an additional seven days. Only then was it reported that the viral culture from the sample was negative for adenovirus.

For real-time PCR: The QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) (13) was utilised to extract viral DNA from 200 μL of VTM in accordance with the manufacturer’s instructions.

The extracted DNA was subsequently processed using real-time PCR. In case of an expected delay in processing, the extracted DNA was stored at -80°C. Stored samples were thawed to room temperature before processing in real-time PCR and repeated freeze-thaw cycles were avoided.

The Helini Adenovirus Real-time PCR kit was used to perform real-time PCR according to its protocol. This kit targets the conserved region of the adenovirus genome, specifically the hexon sequence, for the direct detection of the specific amplicon in the Fam channel. An external positive control was supplied in the kit, which can be used for both qualitative and quantitative determination of viral load. The primers and probe sequences in this kit have 100% homology with a broad range of clinically relevant adenovirus groups and genotypes based on comprehensive bioinformatics analysis.

The HAdV has been categorised into seven subgenera: A-G, as per the International Committee on Taxonomy of Viruses (ICTV). A complete set of 90 genotypes has been identified phylogenetically using all of the genome sequences in the GenBank collection (14).

Widespread epidemics of keratoconjunctivitis are caused by adenoviruses 8, 19, 37, 53 and 54. The following genotypes are implicated in adenoviral conjunctivitis (15).

A: 12, 18, 31
B: 3, 7, 11, 14, 16, 21, 34, 35, 50, 55
C: 1, 2, 5, 6, 57
D: 8, 9, 10, 13, 15, 17, 19, 20, 22, 23, 24, 25, 26, 27, 28, 29, 30, 32, 33, 36, 37, 38, 39, 42, 43, 44, 45, 46, 47, 48, 49, 51, 53, 54, 56
E: 4
F: 40, 41
G: 52

Volume to be added per reaction is as per (Table/Fig 1).

A 10 μL of PCR grade water was added as Negative template control.

Thermal cycler programming was performed as per (Table/Fig 2).

Any sample showing amplification curve along with ct value of <35 was considered as positive after Internal control validation.

Qualitative Interpretation of results was according to (Table/Fig 3).

Statistical Analysis

The data were analysed using Statistical Package for the Social Sciences (SPSS) software version 28.0. The collected data will be statistically analysed using descriptive statistics, specifically mean, standard deviation and percentage, wherever applicable.

Results

The majority of patients in the present study were in the age group of 18-45 years, comprising 25 (56%) of the total patients. The age groups of <18 years and >45 years together constituted 20 (44%) of the study population. The study showed a male preponderance, with 27 (60%) male patients among the total included. All patients exhibited lacrimation as a symptom and 44 (97.7%) presented with red conjunctiva, either unilaterally 17 patients, (37.7%) or bilaterally 28 patients, (62.2%). Additionally, 19 (42.2%) patients showed signs of epibulbar or tarsal follicles, while only one patient exhibited signs of corneal involvement. Furthermore, 7 (15.5%) patients reported having similar symptoms in the past. The representation of clinical features among the patients is shown in (Table/Fig 4).

Out of 45 conjunctival samples tested, 8 (17.7%) were positive for adenovirus in real-time PCR. All eight PCR-positive samples exhibited CPEs in viral cell culture using the A549 cell line. An uninfected A549 cell line is depicted in (Table/Fig 5). The CPE were observed in the form of cell rounding, cell detachment from the flask surface and clustering of the cells to form grape-like clusters, as shown in (Table/Fig 6),(Table/Fig 7).

In all cases, CPE developed within 4-5 days of inoculation. The presence of CPE was confirmed by detecting the adenovirus using the Helini Adenoviral real-time PCR kit (16) on the viral cell medium after viral growth was observed. The present study showed the presence and cell culture recovery of adenovirus in at least 6 (13.3%) of the conjunctival swab samples tested. In this study, 8 (17.7%) samples tested positive by PCR. Confirmatory PCR was positive for 6 out of the eight samples (75%) that showed CPE. The adenoviral real-time PCR amplification plot for a positive sample, along with the internal control, is shown in (Table/Fig 8).

Discussion

Adenoviral conjunctivitis is a communicable disease that can be acquired both nosocomially and in the community. Nosocomial conjunctivitis infections are particularly common, leading to severe outbreaks in ophthalmology wards. These outbreaks can force the limitation of clinical practices, including the delay of eye surgeries, early discharge of hospital inpatients and even the closure of ophthalmology wards (17). Currently, there is no effective treatment for adenoviral conjunctivitis, making prompt detection of the aetiological agent crucial. This is important not only to initiate preventive measures due to the condition’s tendency to cause outbreaks and visual impairment but also because its clinical presentation can mimic other conditions that cause conjunctivitis (11). The current study aimed to accurately diagnose Adenovirus from conjunctival swab samples collected from clinically suspected cases of viral conjunctivitis using real-time PCR and viral cell culture.

The age group distribution, gender distribution and clinical features in this present study were consistent with findings from separate studies conducted by Singh MP et al., Sundaramurthy R et al., and Gopalkrishna V et al., (5),(6),(12). In the study population, the majority of cases were young adults (ages 18-45) and most cases were male 27 (60%), which can be attributed to their increased outdoor activities and, consequently, a higher risk of exposure. The symptomatic observations revealed that lacrimation (100%) and red conjunctiva (97.7%) were the most prevalent symptoms, consistent with the findings of the study conducted by Beniwal N et al., (18).

The present study found PCR positivity in 8 samples (17.7%), while adenoviral recovery via cell culture was 13.3%, similar to the study conducted by Goudarzi H et al., (19). This study showed a 75% adenoviral cell culture recovery rate from PCR-positive samples (6 out of the eight PCR-positive samples), which is comparable to the study conducted by Yag? ci R et al., (10).

In the present study, it was noted that only six of the eight PCR-positive samples could be identified using viral culture. Two samples that tested positive by PCR were not detected in the viral culture, despite the fact that culture is regarded as the reference test. The confirmatory PCR from the viral culture medium for these two samples was negative. These two samples exhibited CPE, which could be due to the presence of other viruses in the samples, such as Coxsackie, Enterovirus, or Herpes. Results of other similar studies as compared to the present study is depicted in (Table/Fig 9) (5),(6),(10),(12),(19).

The diagnostic techniques for conjunctivitis include PCR, direct immunofluorescence and rapid antigen-detection immunoassays. Although viral cell cultures of conjunctival samples are less common due to the requirement for sophisticated equipment and skilled laboratory personnel and because they take longer to yield results, they can be useful in confirming the presence of adenovirus using immunofluorescence. The most accurate standard approach for diagnosing viral conjunctivitis is PCR, as many studies and research investigations have demonstrated (20).

Outbreaks of adenoviral conjunctivitis occur in healthcare facilities, educational institutions and communities. With the application of PCR testing, the adenovirus can be promptly identified as the causative agent, allowing infection control measures to be implemented to prevent the virus from spreading. By providing information on the prevalence and epidemiology of adenoviral conjunctivitis, PCR testing aids in surveillance efforts. Public health officials can use this information to monitor trends, implement preventative measures and organise responses to outbreaks.

Limitation(s)

The present study did not include the detection of other causative agents of viral conjunctivitis.

Conclusion

The present study suggests the presence of adenovirus causing conjunctivitis among patients attending a tertiary care centre in Bengaluru. Real-time PCR has become a standard diagnostic procedure for the detection of adenoviral conjunctivitis. With real-time PCR, adenoviral infections can be accurately detected, preventing misdiagnosis that could otherwise spread the infection. This method provides medical professionals with additional information, enabling them to utilise cutting-edge treatments and make informed clinical decisions.

References

1.
Lynch III JP, Kajon AE. Adenovirus: Epidemiology, global spread of novel serotypes, and advances in treatment and prevention. InSeminars in Respiratory and Critical Care Medicine. 2016;37(4):586-602). Thieme Medical Publishers. [crossref][PubMed]
2.
Pihos AM. Epidemic keratoconjunctivitis: A review of current concepts in management. Journal of Optometry. 2013;6(2):69-74. [crossref][PubMed]
3.
Zhang L, Zhao N, Sha J, Wang C, Jin X, Amer S, Liu S. Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953-2013. Epidemiology & Infection. 2016;144(8):1661-72. [crossref][PubMed]
4.
Madhavan H. Laboratory investigations on viral and Chlamydia trachomatis infections of the eye: SankaraNethralaya experiences. Indian Journal of Ophthalmology. 1999;47(4):241-46.
5.
Gopalkrishna V, Ganorkar NN, Patil PR. Identification and molecular characterization of adenovirus types (HAdV-8, HAdV-37, HAdV-4, HAdV-3) in an epidemic of keratoconjunctivitis occurred in Pune, Maharashtra, Western India. Journal of Medical Virology. 2016;88(12):2100-05. [crossref][PubMed]
6.
Singh MP, Ram J, Kumar A, Rungta T, Gupta A, Khurana J, et al. Molecular epidemiology of circulating human adenovirus types in acute conjunctivitis cases in Chandigarh, North India. Indian Journal of Medical Microbiology. 2018;36(1):113-15. [crossref][PubMed]
7.
Leland DS, Ginocchio CC. Role of cell culture for virus detection in the age of technology. Clinical Microbiology Reviews. 2007;20(1):49-78. [crossref][PubMed]
8.
Starr K, Greninger AL, Makhsous N, Jerome KR, Cook L. Comparison of three adenovirus quantitative PCR assays with ATCC reference strains and clinical samples. Journal of Clinical Microbiology. 2019;57(11):10-128. [crossref][PubMed]
9.
Solanke PV, Pawde P. P Valli. Prevalence of conjunctivitis among the Population of Kanyakumari District. International Journal of Contemporary Medical Research. 2017;4(7):1466-67.
10.
Yağci R, Akçali A, YağCi S, Konno T, Ishiko H, Duman S, et al. Molecular identification of adenoviral conjunctivitis in Turkey. European Journal of Ophthalmology. 2010;20(4):669-74. [crossref][PubMed]
11.
Sharmila F, Singh MP, Shastry J, Phukan AC, Kaliaperumal S, Ratho RK, et al. Epidemiology of keratoconjunctivitis across India from 2017 to 2019: A multicentric hospital-based study. Ophthalmic Epidemiol. 2024;31(5):439-47.[crossref][PubMed]
12.
Sundaramurthy R, Dhodapkar R, Kaliaperumal S, Harish BN. Investigational approach to adenoviral conjunctivitis: Comparison of three diagnostic tests using a Bayesian latent class model. The Journal of Infection in Developing Countries. 2018;12(01):043- 51. [crossref][PubMed]
13.
Qiagen Quick-start protocol: QIAamp DNA mini kit, QIAGEN. Available from: https://www.qiagen.com/us/resources/resourcedetail?id=566f1cb1-4ffe-4225- a6de-6bd3261dc920&lang=en.
14.
Robinson CM, Singh G, Lee JY, Dehghan S, Rajaiya J, Liu EB, et al. Molecular evolution of human adenoviruses. Scientific Reports. 2013;3(1):1812. [crossref][PubMed]
15.
Adams MJ, Lefkowitz EJ, King AM, Harrach B, Harrison RL, Knowles NJ, et al. Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2017). Archives of Virology. 2017;162(8):2505-38. [crossref][PubMed]
16.
Helini Adenovirus Real-time PCR Kit; Available from: https://www.helini.in/ uploads/3/0/9/5/30951267/helini_adenovirus_real-time_pcr_kit.pdf.
17.
Aoki K, Kaneko H, Kitaichi N, Ohguchi T, Tagawa Y, Ohno S. Clinical features of adenoviral conjunctivitis at the early stage of infection. Japanese Journal of Ophthalmology. 2011;55:11-15. [crossref][PubMed]
18.
Beniwal N, Parvez R, Saharan B, Malik V, Dhodapkar R, Muruganandam N, et al. Adenoviral conjunctivitis in the Andaman Islands: A clinical and molecular epidemiological study. Cureus. 2023;15(12):e51241. [crossref][PubMed]
19.
Goudarzi H, Rostami S, Eslami G, Soleymani RA, Miraghasi F, Besharat M, et al. Frequency of adenoviral conjunctivitis by cell culture and PCR method in two referral university hospitals in Tehran. Arch Clin Infect Dis. 2006;1(3):127-29.
20.
Johari Moghadam MM, MohamadYari M, AziziJalilian F, Amini R, Bazzazi N. Epidemiology and molecular diagnosis of acute conjunctivitis in patients attending Hamadan, west Iran ophthalmology clinics 2016-2017. Clinical Optometry. 2019;11:105-11.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2024/72529.20232

Date of Submission: May 01, 2024
Date of Peer Review: Jul 02, 2024
Date of Acceptance: Oct 01, 2024
Date of Publishing: Nov 01, 2024

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: May 01, 2024
• Manual Googling: Jul 08, 2024
• iThenticate Software: Jul 30, 2024 (12%)

ETYMOLOGY: Author Origin

EMENDATIONS: 7

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com